EmphyClear Oral Spray (sodium pyruvate)
/ EmphyCorp
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 13, 2022
Sodium Pyruvate Nasal Spray Reduces the Severity of Nasal Inflammation and Congestion in Patients with Allergic Rhinitis.
(PubMed, J Aerosol Med Pulm Drug Deliv)
- " The intranasal administration of sodium pyruvate significantly improved nasal inflammation scores in all five clinical trials of patients with AR (p < 0.0001 in all trials). These results give credence to the overall ability of sodium pyruvate, administered by nasal spray, to treat inflammation of the nasal airways."
Journal • Allergic Rhinitis • Immunology • Inflammation • Respiratory Diseases • CCL2 • CXCL8 • IL6
April 08, 2022
Sodium Pyruvate Inhalation for COVID-19 Long Hauler Symptoms – An Effective and Inexpensive Treatment
(IMMUNOLOGY 2022)
- "This study examined the effects of N115 treatment on the symptoms associated with COVID-19 long haulers. We have observed significant improvement in SaO2 levels, trouble breathing and fewer headaches indicating that N115 is a potential therapeutic for a major disease with few current options for treatment."
Chronic Obstructive Pulmonary Disease • Fatigue • Fibrosis • Idiopathic Pulmonary Fibrosis • Immunology • Infectious Disease • Novel Coronavirus Disease • Pain • Pulmonary Disease • Respiratory Diseases
1 to 2
Of
2
Go to page
1